Mobile

Doppel-blinde, randomisierte, kontrollierte Studie zur Erfassung des Effektes einer intrakoronaren Applikation von Knochenmark-Progenitorzellen auf die koronare Flußreserve bei Patienten mit akutem Ko...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004874-14

Doppel-blinde, randomisierte, kontrollierte Studie zur Erfassung des Effektes einer intrakoronaren Applikation von Knochenmark-Progenitorzellen auf die koronare Flußreserve bei Patienten mit akutem Koronarsyndrom (Reinfusion of Enriched Progenitor Cells And Infarct Remodeling in Acute Coronary Syndrome; REPAIR - ACS)

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

Myocardial infarction leads to microvascular dysfunction with consecutively reduced coronary flow reserve, which persists after 4 months. Moreover, recent clinical trials have shown that a reduced coronary flow reserve is associated with adverse outcome in the future. Intracoronary infusion of bone marrow-derived progenitor cells lead to complete normalization of coronary blood flow, as demonstrated by the placebo-controlled, double-blind REPAIR-AMI trial, suggesting increased neovascularization by the infused cells . Therefore, the primary objective of the current trial is to improve coronary flow reserve in patients with NSTEMI by intracoronary infusion of autologous bone marrow-derived mononuclear progenitor cells, compared with a placebo group, in a double-blind way.

Critère d'inclusion

  • Patients with acute coronary syndrome (NSTEMI) due to coronary artery disease

Liens